Key Takeaways:
- James Hardie sells Fermacell to Holcim for €840 million in cash
- Company also closing European fiber cement business to exit the region
- $600 million of proceeds to repay debt; $250 million buyback authorized
Key Takeaways:

James Hardie is exiting Europe entirely, selling its Fermacell walling business to Holcim for €840 million while closing its fiber cement operations.
James Hardie Industries agreed to sell its European Fermacell walling and flooring business to Holcim for €840 million in cash, roughly $980 million, as the building-materials maker exits Europe to focus on higher-growth markets.
"The strategic divestiture of our European operations and the intended closure of the European fiber cement business will enable us to focus on our highest growth and return opportunities," said Aaron Erter, CEO of James Hardie.
The transaction, expected to close in the first half of calendar 2027, includes the fermacell and Aestuver brands. James Hardie also intends to shut its European fiber cement business, subject to legal, regulatory and works council consultations. The company plans to use approximately $600 million of proceeds to repay debt, accelerating progress toward its net leverage target below 2.0x by Sept. 30, 2027, and its board authorized a new $250 million share repurchase program.
The divestiture is expected to be accretive to margin profile and return on invested capital post-close, and it marks a decisive shift for James Hardie, which will now concentrate entirely on North America and Australia-New Zealand. For Holcim, the acquisition deepens its building-solutions portfolio in Europe, adding fiber cement to its existing roofing, insulation and modular construction offerings.
A Clean Break From Europe
The sale follows James Hardie's broader portfolio realignment, which included the acquisition of AZEK Exteriors and TimberTech as the company pivots toward outdoor living and exterior solutions. The European fiber cement closure, subject to employee consultation requirements including competent works councils, will remove a business that has struggled to match the profitability of the company's North American operations.
Fermacell produces sustainable gypsum fiberboard for walling, flooring and ceiling applications, with the Aestuver brand covering acoustic and fire-resistant boards. The business has been a growth platform for James Hardie in Europe, but the company has determined that its capital and management attention are better deployed in North America, where its Hardie-branded fiber cement siding commands a leading position in the residential exterior market.
Christian Claus, CEO of Fermacell and President of James Hardie Europe, will continue to lead the Fermacell business under Holcim's ownership. "Holcim is a strong strategic fit for the Fermacell business, and importantly, customers will continue to receive high quality and excellent service," Claus said.
Goldman Sachs & Co. LLC served as financial advisor to James Hardie, with DLA Piper as legal advisor.
Capital Returns and Deleveraging
The $980 million cash infusion arrives as James Hardie works through integration of its AZEK acquisition. The company's net leverage target of below 2.0x by September 2027 will be accelerated by the $600 million debt repayment, while the $250 million buyback program reflects management's confidence in the remaining portfolio's cash generation.
For Holcim, the deal extends a strategy of shifting toward higher-value building solutions rather than relying on traditional cement and aggregates. The Swiss group, with a market value around $55 billion, gains access to Europe's repair, renovation and energy-efficiency markets, which have shown more resilient demand than new construction during periods of elevated interest rates.
The European construction sector has faced pressure from high financing costs and weak housing demand, yet renovation activity and energy-efficiency upgrades continue to create demand for higher-performance building materials. The transaction is expected to close in the first half of 2027, subject to regulatory approvals and employee consultation processes.
This article is for informational purposes only and does not constitute investment advice.